The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Phyllodes Tumor

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Phyllodes Tumor


High impact information on Phyllodes Tumor


Chemical compound and disease context of Phyllodes Tumor


Biological context of Phyllodes Tumor


Anatomical context of Phyllodes Tumor


Gene context of Phyllodes Tumor


Analytical, diagnostic and therapeutic context of Phyllodes Tumor


  1. Two germ-line mutations affecting the same nucleotide at codon 257 of p53 gene, a rare site for mutations. Mazoyer, S., Lalle, P., Moyret-Lalle, C., Marçais, C., Schraub, S., Frappaz, D., Sobol, H., Ozturk, M. Oncogene (1994) [Pubmed]
  2. Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast. Sapino, A., Bosco, M., Cassoni, P., Castellano, I., Arisio, R., Cserni, G., Tos, A.P., Fortunati, N., Catalano, M.G., Bussolati, G. Mod. Pathol. (2006) [Pubmed]
  3. Multifocal intrafollicular granulosa cell tumor of the ovary associated with an unusual germline p53 mutation. Nogales, F.F., Musto, M.L., Sáez, A.I., Robledo, M., Palacios, J., Aneiros, J. Mod. Pathol. (2004) [Pubmed]
  4. Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections. Moritani, S., Kushima, R., Sugihara, H., Bamba, M., Kobayashi, T.K., Hattori, T. Mod. Pathol. (2002) [Pubmed]
  5. Malignant phyllodes tumor of the breast with hypoglycemia: report of a case. Kataoka, T., Haruta, R., Goto, T., Sugino, K., Asahara, T., Dohi, K., Kaneco, M., Arihiro, K., Nomura, S. Jpn. J. Clin. Oncol. (1998) [Pubmed]
  6. Abundant expression of immunoreactive endothelin 1 in mammary phyllodes tumor: possible paracrine role of endothelin 1 in the growth of stromal cells in phyllodes tumor. Yamashita, J., Ogawa, M., Egami, H., Matsuo, S., Kiyohara, H., Inada, K., Yamashita, S., Fujita, S. Cancer Res. (1992) [Pubmed]
  7. Cystosarcoma phylloides. A steroid receptor and ultrastructure analysis. Kesterson, G.H., Georgiade, N., Seigler, H.F., Barton, T.K., McCarty, K.S., McCarty, K.S. Ann. Surg. (1979) [Pubmed]
  8. Evaluation of MYC and chromosome 8 copy number in breast carcinoma by interphase cytogenetics. Visscher, D.W., Wallis, T., Awussah, S., Mohamed, A., Crissman, J.D. Genes Chromosomes Cancer (1997) [Pubmed]
  9. Amplifications of the epidermal growth factor receptor gene (egfr) are common in phyllodes tumors of the breast and are associated with tumor progression. Kersting, C., Kuijper, A., Schmidt, H., Packeisen, J., Liedtke, C., Tidow, N., Gustmann, C., Hinrichs, B., Wülfing, P., Tio, J., Boecker, W., van Diest, P., Brandt, B., Buerger, H. Lab. Invest. (2006) [Pubmed]
  10. Increased c-kit (CD117) expression in malignant mammary phyllodes tumors. Tse, G.M., Putti, T.C., Lui, P.C., Lo, A.W., Scolyer, R.A., Law, B.K., Karim, R., Lee, C.S. Mod. Pathol. (2004) [Pubmed]
  11. Progesterone receptor in cystosarcoma phyllodes. Rao, B.R., Meyer, J.S. Archives of surgery (Chicago, Ill. : 1960) (1977) [Pubmed]
  12. Antigenic profile of mammary fibroadenoma and cystosarcoma phyllodes. A study using antibodies to estrogen- and progesterone receptors and to a panel of cell surface molecules. Mechtersheimer, G., Krüger, K.H., Born, I.A., Möller, P. Pathol. Res. Pract. (1990) [Pubmed]
  13. Gallium-67 uptake in cystosarcoma phyllodes. Silver, M.R. AJR. American journal of roentgenology. (1982) [Pubmed]
  14. Increased activity in benign phyllodes tumor on Tc-99m MDP scintimammography. Katayama, N., Inoue, Y., Ichikawa, T., Harada, M., Itoh, T., Shimoyamada, K., Ikeda, M., Tsukune, Y. Clinical nuclear medicine. (2000) [Pubmed]
  15. Cytogenetics, immunostaining for fibroblast growth factors, p53 sequencing, and clinical features of two cases of cystosarcoma phyllodes. Woolley, P.V., Gollin, S.M., Riskalla, W., Finkelstein, S., Stefanik, D.F., Riskalla, L., Swaney, W.P., Weisenthal, L., McKenna, R.J. Mol. Diagn. (2000) [Pubmed]
  16. Prognostic evaluation of proliferative activity and DNA content in the phyllodes tumor of the breast: immunohistochemical and flow cytometric study of 118 cases. Niezabitowski, A., Lackowska, B., Rys, J., Kruczak, A., Kowalska, T., Mitus, J., Reinfuss, M., Markiewicz, D. Breast Cancer Res. Treat. (2001) [Pubmed]
  17. p53 protein expression and gene mutation in phyllodes tumors of the breast. Gatalica, Z., Finkelstein, S., Lucio, E., Tawfik, O., Palazzo, J., Hightower, B., Eyzaguirre, E. Pathol. Res. Pract. (2001) [Pubmed]
  18. Estradiol binding protein in cystosarcoma phyllodes of the breast. Palshof, T., Blichert-Toft, M., Daehnfeldt, J.L., Naylor, B., Jacobsen, G.K., Jensen, H., Schiødt, T. European journal of cancer. (1980) [Pubmed]
  19. Molecular assessment of clonality leads to the identification of a new germ line TP53 mutation associated with malignant cystosarcoma phyllodes and soft tissue sarcoma. Bot, F.J., Sleddens, H.F., Dinjens, W.N. Diagn. Mol. Pathol. (1998) [Pubmed]
  20. Steroid receptors in sarcomatous lesions. Lee, Y.T., Markland, F.S. Journal of surgical oncology. (1979) [Pubmed]
  21. Intermediate-sized filament proteins (keratin, vimentin, desmin) in metaplastic carcinomas, carcinosarcomas and stromal sarcomas of the breast. Santini, D., Bazzocchi, F., Paladini, G., Gelli, M.C., Ricci, M., Mazzoleni, G., Martinelli, G. Int. J. Biol. Markers (1987) [Pubmed]
  22. Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast. Kuijper, A., van der Groep, P., van der Wall, E., van Diest, P.J. Breast Cancer Res. (2005) [Pubmed]
  23. Coexistence of intracytoplasmic lumens and membrane-bound vesicles in an invasive carcinoma arising in a cystosarcoma phyllodes. Gilks, B., Tavassoli, F.A. Ultrastructural pathology. (1988) [Pubmed]
  24. CD34, CD117, and actin expression in phyllodes tumor of the breast. Chen, C.M., Chen, C.J., Chang, C.L., Shyu, J.S., Hsieh, H.F., Harn, H.J. J. Surg. Res. (2000) [Pubmed]
  25. Metaplastic breast carcinomas: are they of myoepithelial differentiation?: immunohistochemical profile of the sarcomatoid subtype using novel myoepithelial markers. Leibl, S., Gogg-Kammerer, M., Sommersacher, A., Denk, H., Moinfar, F. Am. J. Surg. Pathol. (2005) [Pubmed]
  26. p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma. Koker, M.M., Kleer, C.G. Am. J. Surg. Pathol. (2004) [Pubmed]
  27. Proliferating activity in differential diagnosis of benign phyllodes tumor and cellular fibroadenomas: is it helpful? Kaya, R., Pestereli, H.E., Erdogan, G., Gülkesen, K.H., Karaveli, S. Pathol. Oncol. Res. (2001) [Pubmed]
WikiGenes - Universities